Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry.

[1]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[2]  H. Wijeysundera,et al.  Reporting and representation of ethnic minorities in cardiovascular trials: a systematic review. , 2013, American heart journal.

[3]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[4]  E. Peterson,et al.  Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing?: an analysis of 107,096 patients from the National Cardiovascular Data Registry's ICD Registry. , 2012, Journal of the American College of Cardiology.

[5]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, Journal of the American College of Cardiology.

[6]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. , 2012, Circulation.

[7]  G. Fonarow,et al.  Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF. , 2012, Journal of the National Medical Association.

[8]  Kevin L. Thomas,et al.  Trends in Use of Implantable Cardioverter-Defibrillator Therapy Among Patients Hospitalized for Heart Failure: Have the Previously Observed Sex and Racial Disparities Changed Over Time? , 2012, Circulation.

[9]  J. Healey,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[10]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[11]  J. Kirkpatrick,et al.  Ethnic and racial disparities in cardiac resynchronization therapy. , 2009, Heart rhythm.

[12]  M. Kosorok,et al.  Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure: Results From the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Trial , 2009, Circulation.

[13]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[14]  J. Ornato,et al.  ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2008, Heart rhythm.

[15]  D. Mark,et al.  Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). , 2008, American heart journal.

[16]  Stephen W Lagakos,et al.  Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.

[17]  C. Yancy,et al.  Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. , 2007, JAMA.

[18]  R. Redberg.  Disparities in use of implantable cardioverter-defibrillators: moving beyond process measures to outcomes data. , 2007, JAMA.

[19]  Kevin L. Thomas,et al.  Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of , 2007, The American journal of cardiology.

[20]  C. O'connor,et al.  Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. , 2007, American heart journal.

[21]  A. Moss,et al.  Effectiveness of the implantable cardioverter defibrillator in blacks versus whites (from MADIT-II). , 2006, The American journal of cardiology.

[22]  E. Emanuel,et al.  Are Racial and Ethnic Minorities Less Willing to Participate in Health Research? , 2005, PLoS medicine.

[23]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[24]  A. Russo,et al.  Racial Differences in Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT) A Comparison of Whites Versus Blacks , 2003, Circulation.

[25]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[26]  M. Gold.  Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events , 2010 .

[27]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[28]  J. Oss,et al.  IMPROVED SURVIVAL WITH AN IMPLANTED DEFIBRILLATOR IN PATIENTS WITH CORONARY DISEASE AT HIGH RISK FOR VENTRICULAR ARRHYTHMIA , 1996 .